VanEck Biotech ETF (NASDAQ:BBH) Sees Strong Trading Volume – Here’s What Happened

VanEck Biotech ETF (NASDAQ:BBH) saw strong trading volume on Friday. Approximately 10,143 shares changed hands during trading, an increase of 36% from the average daily volume of 7,443 shares. The stock last traded at $259.4760 and had previously closed at $256.90.

VanEck Biotech ETF Stock Up 0.5%

The stock’s 50 day moving average is $240.60 and its two-hundred day moving average is $206.44.

Hedge Funds Weigh In On VanEck Biotech ETF

Hedge funds and other institutional investors have recently modified their holdings of the business. Nwam LLC purchased a new position in VanEck Biotech ETF in the second quarter worth approximately $18,614,000. Ascent Advisors LLC purchased a new stake in shares of VanEck Biotech ETF during the 1st quarter worth approximately $11,178,000. LGL Partners LLC purchased a new stake in VanEck Biotech ETF in the second quarter valued at approximately $2,298,000. Proficio Capital Partners LLC purchased a new stake in shares of VanEck Biotech ETF in the second quarter valued at about $5,183,000. Finally, Segall Bryant & Hamill LLC acquired a new position in VanEck Biotech ETF in the 1st quarter valued at $881,000. 32.05% of the stock is owned by hedge funds and other institutional investors.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.